← back to search

Susan Mathers

Monash Health · AU
Area of research
Neurology · Genetics
Research interest
Research focused on Amyotrophic lateral sclerosis and DNA methylation, with related work in Genetics, Disease, Locus (genetics). Notable publications include 'Assessment of Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis in 4 Patients', 'Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders', and 'Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial'.
h-index
citations
825
works
12
NIH funding
primary concept
email

Recent publications

Amyotrophic lateral sclerosis established as a multistep process across phenotypes
European Journal of Neurology 2024cited by 11position: middledoi
Assessment of Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis in 4 Patients
JAMA Neurology 2023cited by 162position: middledoi
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS
Science Translational Medicine 2022cited by 91position: middledoi
Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1
Genome Medicine 2022cited by 38position: middledoi
Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders
Genome biology 2021cited by 104position: middledoi
Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy
Journal of the Neurological Sciences 2021cited by 52position: middledoi
Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study
Annals of Clinical and Translational Neurology 2021cited by 42position: middledoi
Genome-wide Meta-analysis Finds the ACSL5-ZDHHC6 Locus Is Associated with ALS and Links Weight Loss to the Disease Genetics
Cell Reports 2020cited by 61position: middledoi
Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis
npj Genomic Medicine 2020cited by 35position: middledoi
Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019cited by 100position: middledoi
Motor neurone disease: progress and challenges
The Medical Journal of Australia 2017cited by 53position: middledoi
Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort
BMJ Open 2016cited by 76position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matthew C. Kiernan · South Western Sydney Local Health District6 papers (2016–2024)Steve Vucic · The University of Sydney6 papers (2016–2024)Robert D. Henderson · The University of Queensland4 papers (2016–2024)Merrilee Needham · University of Notre Dame4 papers (2016–2024)Dominic B. Rowe · Macquarie University3 papers (2016–2021)David Schultz · University of Evansville3 papers (2016–2021)Ruben P. A. van Eijk · Utrecht University3 papers (2019–2024)Paul Talman · Deakin University3 papers (2016–2024)Avindra Nath · National Institutes of Health2 papers (2019–2021)Puja R. Mehta · Queen Mary University of London2 papers (2019–2021)Gina Norato · University of Arizona2 papers (2019–2021)Ulisses A. Santamaria · National Institute of Neurological Disorders and Stroke2 papers (2019–2021)Mary‐Louise Rogers · Flinders University2 papers (2019–2021)Henk‐Jan Westeneng · Utrecht University2 papers (2019–2021)Marta García‐Montojo · National Institute of Neurological Disorders and Stroke2 papers (2019–2021)Ammar Al‐Chalabi · Cambridge University Hospitals NHS Foundation Trust2 papers (2019–2021)Vittoria Lombardi · University of Padua2 papers (2019–2021)Pamela McCombe · Prince Charles Hospital2 papers (2016–2024)Julian Gold · Princeton University2 papers (2019–2021)Andrea Malaspina · Motor Neurone Disease Association2 papers (2019–2021)